United Therapeutics (UTHR) Exchange Rate Effect (2009 - 2017)
United Therapeutics (UTHR) reported Exchange Rate Effect of -$200000.0 for Q3 2017, up 80.0% on a YoY basis from -$111111.1 in Q3 2016, and little changed sequentially from -$200000.0 in Q4 2016.
United Therapeutics (UTHR) Exchange Rate Effect (2009 - 2017) Analysis & Trends
United Therapeutics (UTHR) has 9 years of Exchange Rate Effect data on file, last reported at -$200000.0 in Q3 2017.
- For the quarter ending Q3 2017, Exchange Rate Effect rose 80.0% year-over-year to -$200000.0; the trailing twelve-month figure through Dec 2017 stood at -$1.4 million (up 53.33% YoY), and the FY2017 full-year result was $200000.0, up 106.67% from the prior year.
- Exchange Rate Effect steadied at -$200000.0 in Q3 2017, from -$200000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.5 million in Q2 2015 to a low of -$3.1 million in Q1 2015.
- A 5-year average of -$742294.1 and a median of -$295000.0 in 2013 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 374.68% in 2015, while the deepest fall reached 1912.99% in 2015.
- Tracing UTHR's Exchange Rate Effect over 5 years: stood at -$295000.0 in 2013, then sank by 892.54% to -$2.9 million in 2014, then jumped by 45.36% to -$1.6 million in 2015, then surged by 87.5% to -$200000.0 in 2016, then changed by 0.0% to -$200000.0 in 2017.
- Business Quant data shows UTHR's Exchange Rate Effect at -$200000.0 in Q3 2017, -$200000.0 in Q4 2016, and -$1.0 million in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -200,000.00 |
| Sep 30, 2017 | -200,000.00 |
| Dec 31, 2016 | -200,000.00 |
| Dec 31, 2016 | -200,000.00 |
| Sep 30, 2016 | -1.00 Mn |
| Sep 30, 2016 | -1.00 Mn |
| Jun 30, 2016 | -2.20 Mn |
| Jun 30, 2016 | -2.20 Mn |
| Mar 31, 2016 | 400,000.00 |
| Mar 31, 2016 | 400,000.00 |
| Dec 31, 2015 | -1.60 Mn |
| Dec 31, 2015 | -1.60 Mn |
| Sep 30, 2015 | -2.10 Mn |
| Sep 30, 2015 | -2.10 Mn |
| Jun 30, 2015 | 1.50 Mn |
| Jun 30, 2015 | 1.50 Mn |
| Mar 31, 2015 | -3.10 Mn |
| Mar 31, 2015 | -3.10 Mn |
| Dec 31, 2014 | -2.93 Mn |
| Dec 31, 2014 | -2.93 Mn |